How many tablets is too many tablets a day?
At Dow Wolff Cellulosics, we are leading the effort in controlled release technology. Our goal is simple: ensure the right amount of a drug’s active ingredient is released from a tablet in the right place and at the right time.
Controlled release medication can mean the difference between taking a tablet once a day rather than once every few hours.
Trust the Dow Wolff Cellulosics Advantage
METHOCEL™ Premium Controlled Release (CR) Grade products have the properties needed to formulate controlled release tablets. That’s why they are the brand of choice for these systems.
- Controlled Drug Delivery: Our CR polymers hydrate the outer tablet surface to form a gel layer on contact with water. The diffusion out of the gel layer or the rate of tablet erosion can be designed to control the overall drug delivery rate. Conversely, our water-insoluble ETHOCEL™ Premium polymers are used in film and bead coating. Combined with our water-soluble METHOCEL™ Premium CR products, they help to leave a non-continuous film on tablets.
- Consistency: METHOCEL™ Premium CR cellulose ethers are specially engineered for pharmaceutical controlled release applications to deliver a consistent drug-release performance. Our proprietary techniques mean you can develop robust formulations quickly and then rely absolutely on their performance.
- Trust: Our CR products are fully certified and have an excellent safety record. We’ll happily provide all necessary data.
A truly global offering with our Colorcon Alliance
The global pharmaceutical industry is demanding ever-faster development and more efficient production of drug ingredients. We’ve addressed this through an alliance with Colorcon for the global marketing, sales, technical service and distribution of these METHOCEL™, ETHOCEL™ and POLYOX™ pharmaceutical excipient products for use in controlled release applications.
This alliance allows Dow Wolff Cellulosics to address customer needs for value-added service throughout the world in controlled release applications. It frees intellectual capital and people resources to develop improved and new technologies to enhance performance during pharmaceutical manufacturing, distribution and use.